We are live on ! Find out more
CERO

CERo Therapeutics
CERO

Delisted

CERO was delisted on the 30th of October, 2025.

Back to rankings

12 hedge funds and large institutions have $10.6M invested in CERo Therapeutics in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% less ownership

Funds ownership: 0.03% → 0.03% (-0%)

15% less capital invested

Capital invested by funds: $12.5M → $10.6M (-$1.93M)

20% less funds holding

Funds holding: 15 → 12 (-3)

50% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 6

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $1.19M

Holders
12
Holders Change
-3
Holders Change %
-20%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
2
Closed
6
Calls
–
Puts
$1.19M
Net Calls
-$1.19M
Net Calls Change
-$1.19M

Top Buyers

Rank Fund Capital Flow
1
CS
Clear Street
New York
+$2.08M
2
YCM
Yakira Capital Management
Connecticut
+$1.17M
3
FIA
FNY Investment Advisers
New York
+$21.7K

Top Sellers

Rank Fund Capital Flow
1
PC
Periscope Capital
Ontario, Canada
-$1.59M
2
KL
KIM LLC
Kansas
-$1.07M
3
SCM
Shaolin Capital Management
Florida
-$1.06M
4
MC
Meteora Capital
Florida
-$585K
5
BFM
Boothbay Fund Management
New York
-$530K
Name Holding Trade Value Shares
Change 		Change in
Stake
CS
1
Clear Street
New York
$2.08M +$2.08M +96 New
MC
2
Meteora Capital
Florida
$1.66M -$585K -27 -26%
MTCM
3
Mint Tower Capital Management
Netherlands
$1.54M – – –
PAMP
4
Polar Asset Management Partners
Ontario, Canada
$1.29M – – –
YCM
5
Yakira Capital Management
Connecticut
$1.18M +$1.17M +54 New
WRBC
6
W.R. Berkley Corp
Connecticut
$1.05M -$43.3K -2 -4%
AA
7
AQR Arbitrage
Connecticut
$863K – – –
Walleye Capital
8
Walleye Capital
New York
$523K – – –
Walleye Trading
9
Walleye Trading
New York
$294K – – –
Geode Capital Management
10
Geode Capital Management
Massachusetts
$114K – – –
FIA
11
FNY Investment Advisers
New York
$22K +$21.7K +1 New
TRCT
12
Tower Research Capital (TRC)
New York
$65 – – –
CF
13
Cantor Fitzgerald
New York
$2 – – –
PC
14
Periscope Capital
Ontario, Canada
– -$1.59M -75 Closed
KL
15
KIM LLC
Kansas
– -$1.07M -50 Closed
SCM
16
Shaolin Capital Management
Florida
– -$1.06M -49 Closed
BFM
17
Boothbay Fund Management
New York
– -$530K -25 Closed
GAM
18
Gritstone Asset Management
Maryland
– -$363K -17 Closed
Susquehanna International Group
19
Susquehanna International Group
Pennsylvania
– -$145K -7 Closed

CERO Hedge Fund Activity: Q2 2023 in Review

12 of the 6,371 institutional investors tracked by Wall St. Rank reported a position in CERo Therapeutics (CERO) for Q2 2023, worth a combined $10.6M — down 15% from $12.5M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of CERO and 3 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 0 added.

The largest buyer was Clear Street, opening a new position worth an estimated $2.08M. The largest seller was Periscope Capital, exiting entirely with an estimated $1.59M sold.

  • 12 institutional investors held CERo Therapeutics (CERO) as of Q2 2023, down from 15 in Q1 2023.
  • Funds reported $10.6M of CERo Therapeutics stock for Q2 2023, down 15% quarter-over-quarter.
  • 3 funds opened new CERo Therapeutics positions in Q2 2023 and 6 closed out, a net change of -3 holders.
  • The largest CERo Therapeutics buyer in Q2 2023 was Clear Street, an estimated $2.08M added.
  • The largest CERo Therapeutics seller in Q2 2023 was Periscope Capital, an estimated $1.59M sold.

Based on aggregated 13F filings for Q2 2023.